Steve Aselage - Net Worth and Insider Trading
Steve Aselage Net Worth
The estimated net worth of Steve Aselage is at least $6 Million dollars as of 2024-06-01. Steve Aselage is the EVP, Chief Business Officer of Biomarin Pharmaceutical Inc and owns about 59,030 shares of Biomarin Pharmaceutical Inc (BMRN) stock worth over $4 Million. Steve Aselage is the Director of Travere Therapeutics Inc and owns about 146,919 shares of Travere Therapeutics Inc (TVTX) stock worth over $1 Million. Steve Aselage is also the Director of BioCryst Pharmaceuticals Inc and owns about 65,839 shares of BioCryst Pharmaceuticals Inc (BCRX) stock worth over $425,978. Besides these, Steve Aselage also holds Acer Therapeutics Inc (ACER) . Details can be seen in Steve Aselage's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Steve Aselage has not made any transactions after 2024-05-24 and currently still holds the listed stock(s).
Transaction Summary of Steve Aselage
Steve Aselage Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Steve Aselage owns 5 companies in total, including BioCryst Pharmaceuticals Inc (BCRX) , Travere Therapeutics Inc (TVTX) , and Acer Therapeutics Inc (ACER) among others .
Click here to see the complete history of Steve Aselage’s form 4 insider trades.
Insider Ownership Summary of Steve Aselage
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| BCRX | BioCryst Pharmaceuticals Inc | 2024-05-24 | director |
| TVTX | Travere Therapeutics Inc | 2022-05-11 | director |
| ACER | Acer Therapeutics Inc | 2022-11-29 | director |
 | | 2012-07-02 | SVP & Global Commercial Ops |
| | 2004-02-02 | EVP & Global Commercial Ops |
Steve Aselage Latest Holdings Summary
Steve Aselage currently owns a total of 4 stocks. Among these stocks, Steve Aselage owns 59,030 shares of Biomarin Pharmaceutical Inc (BMRN) as of July 2, 2012, with a value of $4 Million and a weighting of 70.73%. Steve Aselage owns 146,919 shares of Travere Therapeutics Inc (TVTX) as of May 11, 2022, with a value of $1 Million and a weighting of 17.37%. Steve Aselage also owns 65,839 shares of BioCryst Pharmaceuticals Inc (BCRX) as of May 24, 2024, with a value of $425,978 and a weighting of 6.8%. The other 1 stocks Acer Therapeutics Inc (ACER) have a combined weighting of 5.1% among all his current holdings.
Latest Holdings of Steve Aselage
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| BMRN | Biomarin Pharmaceutical Inc | 2012-07-02 | 59,030 | 75.08 | 4,431,972 |
| TVTX | Travere Therapeutics Inc | 2022-05-11 | 146,919 | 7.41 | 1,088,670 |
| BCRX | BioCryst Pharmaceuticals Inc | 2024-05-24 | 65,839 | 6.47 | 425,978 |
| ACER | Acer Therapeutics Inc | 2022-11-29 | 483,741 | 0.66 | 319,317 |
Holding Weightings of Steve Aselage
Steve Aselage Form 4 Trading Tracker
According to the SEC Form 4 filings, Steve Aselage has made a total of 0 transactions in Biomarin Pharmaceutical Inc (BMRN) over the past 5 years. The most-recent trade in Biomarin Pharmaceutical Inc is the sale of 95,345 shares on July 2, 2012, which brought Steve Aselage around $4 Million.
According to the SEC Form 4 filings, Steve Aselage has made a total of 18 transactions in Travere Therapeutics Inc (TVTX) over the past 5 years, including 0 buys and 18 sells. The most-recent trade in Travere Therapeutics Inc is the sale of 2,575 shares on May 11, 2022, which brought Steve Aselage around $56,444.
According to the SEC Form 4 filings, Steve Aselage has made a total of 2 transactions in BioCryst Pharmaceuticals Inc (BCRX) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in BioCryst Pharmaceuticals Inc is the acquisition of 2,500 shares on May 24, 2024, which cost Steve Aselage around $16,000.
More details on Steve Aselage's insider transactions can be found in the Insider Trading History of Steve Aselage table.Insider Trading History of Steve Aselage
- 1
Steve Aselage Trading Performance
GuruFocus tracks the stock performance after each of Steve Aselage's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Steve Aselage is 13.55%. GuruFocus also compares Steve Aselage's trading performance to market benchmark return within the same time period. The performance of stocks bought by Steve Aselage within 3 months outperforms 4 times out of 8 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Steve Aselage's insider trading performs compared to the benchmark.
Performance of Steve Aselage
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 30.12 | | | | | |
| Relative Return to S&P 500(%) | 28.16 | | | | | |
Steve Aselage Ownership Network
Steve Aselage Owned Company Details
What does BioCryst Pharmaceuticals Inc do?
Who are the key executives at BioCryst Pharmaceuticals Inc?
Steve Aselage is the director of BioCryst Pharmaceuticals Inc. Other key executives at BioCryst Pharmaceuticals Inc include Chief Financial Officer Anthony Doyle , Vice President and CCO Charles K Gayer , and VP & General Counsel & Corp Sec Alane P Barnes .
BioCryst Pharmaceuticals Inc (BCRX) Insider Trades Summary
Over the past 18 months, Steve Aselage made no insider transaction in BioCryst Pharmaceuticals Inc (BCRX). Other recent insider transactions involving BioCryst Pharmaceuticals Inc (BCRX) include a net sale of 381,673 shares made by Jon P Stonehouse , a net purchase of 19,875 shares made by Helen M. Thackray , and a net purchase of 30,600 shares made by Anthony Doyle .
In summary, during the past 3 months, insiders sold 0 shares of BioCryst Pharmaceuticals Inc (BCRX) in total and bought 183,601 shares, with a net purchase of 183,601 shares. During the past 18 months, 455,084 shares of BioCryst Pharmaceuticals Inc (BCRX) were sold and 183,601 shares were bought by its insiders, resulting in a net sale of 271,483 shares.
BioCryst Pharmaceuticals Inc (BCRX)'s detailed insider trading history can be found in Insider Trading Tracker table.
BioCryst Pharmaceuticals Inc Insider Transactions
Steve Aselage Mailing Address
Above is the net worth, insider trading, and ownership report for Steve Aselage. You might contact Steve Aselage via mailing address: 6300 Dumbarton Circle, Fremont Ca 94555.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
